BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,374,000 | -28.2% | 35,549 | -30.8% | 0.19% | -9.4% |
| Q2 2022 | $7,484,000 | +4697.4% | 51,361 | +2313.6% | 0.21% | +2266.7% |
| Q2 2020 | $156,000 | -37.3% | 2,128 | -53.5% | 0.01% | 0.0% |
| Q4 2019 | $249,000 | +352.7% | 4,581 | +243.4% | 0.01% | +350.0% |
| Q3 2019 | $55,000 | -93.6% | 1,334 | -93.3% | 0.00% | -95.2% |
| Q2 2019 | $866,000 | +95.5% | 19,769 | +129.8% | 0.04% | +68.0% |
| Q1 2019 | $443,000 | +5437.5% | 8,603 | +3977.3% | 0.02% | – |
| Q3 2018 | $8,000 | -99.2% | 211 | -99.5% | 0.00% | -100.0% |
| Q1 2018 | $1,023,000 | – | 39,700 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |